Linda Rubinstein
2023 - Avalanche Biotechnologies
In 2023, Linda Rubinstein earned a total compensation of $2.3M as Chief Financial Officer at Avalanche Biotechnologies, a 1,957% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $67,721 |
|---|---|
| Option Awards | $1,360,340 |
| Salary | $198,409 |
| Other | $674,863 |
| Total | $2,301,333 |
Rubinstein received $1.4M in option awards, accounting for 59% of the total pay in 2023.
Rubinstein also received $67.7K in non-equity incentive plan, $198.4K in salary and $674.9K in other compensation.
Rankings
In 2023, Linda Rubinstein's compensation ranked 441st out of 2,978 executives tracked by ExecPay. In other words, Rubinstein earned more than 85.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 441 out of 2,978 | 85th |
Division Manufacturing | 251 out of 1,637 | 85th |
Major group Chemicals And Allied Products | 175 out of 906 | 81st |
Industry group Drugs | 172 out of 869 | 80th |
Industry Biological Products, Except Diagnostic Substances | 60 out of 211 | 72nd |
Pay ratio
| Linda Rubinstein's Pay | $2,301,333 |
|---|---|
| Median Employee's Pay | $229,443 |
| Pay Ratio | 10to 1 |
In 2023, the annual total compensation of Linda Rubinstein was $2,301,333.
The annual total compensation of the median employee at Avalanche Biotechnologies was $229,443.
The ratio of Linda Rubinstein's pay to the pay of median employee was therefore 10 to one.
Source: SEC filing on May 2, 2024.
Rubinstein's colleagues
We found three more compensation records of executives who worked with Linda Rubinstein at Avalanche Biotechnologies in 2023.